Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics.

Filiaciones

Heerlein K:

Janssen EMEA, Neuss, Germany

Young AH:

Institute of Psychiatry, Psychology and Neuroscience, King's College London, Department of Psychological Medicine, London, United Kingdom

South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, United Kingdom

Otte C:

Charité Universitätsmedizin, Berlin, Germany

Frodl T:

Univeritätsklinikum Magdeburg, Otto von Guericke Universität Magdeburg, Magdeburg, Germany

Degraeve G:

AZ Alma General Hospital, Eeklo, Belgium

PC Dr Guislain Hospital, Ghent, Belgium

Hagedoorn W:

Practice for Psychiatry and Psychotherapy, Heerde, Netherlands

Oliveira-Maia AJ:

Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal

NOVA Medical School, NMS, Universidade Nova de Lisboa, Lisbon, Portugal

Perez Sola V:

Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona IMIM Hospital del Mar Medical Research Institute, Univ Autonoma de Barcelona, CIBERSAM, Department of Psychiatry, Barcelona, Spain

Rathod S:

Southern Health NHS Foundation Trust, Research Department, Tom Rudd Unit, Southampton, United Kingdom

Rosso G:

San Luigi Gonzaga Hospital, Department of Neurosciences, University of Turin, Turin, Italy

Sierra P:

University and Polytechnic Hospital La Fe, Valencia, University of Valencia, Spain

Morrens J:

Janssen EMEA, Beerse, Belgium

Van Dooren G:

Janssen EMEA, Beerse, Belgium

Gali Y:

Janssen EMEA, Beerse, Belgium

Perugi G:

University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy